SFA Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- SFA Therapeutics's estimated annual revenue is currently $1.7M per year.
- SFA Therapeutics's estimated revenue per employee is $155,000
Employee Data
- SFA Therapeutics has 11 Employees.
- SFA Therapeutics grew their employee count by 10% last year.
SFA Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO, Co-Founder | Reveal Email/Phone |
2 | COO, Executive Founder | Reveal Email/Phone |
SFA Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 9 | -10% | N/A | N/A |
#2 | $7.1M | 46 | 77% | N/A | N/A |
#3 | $14.4M | 93 | 27% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $1.6M | 10 | 43% | N/A | N/A |
#6 | $11.5M | 74 | 6% | N/A | N/A |
#7 | $0.9M | 11 | 22% | N/A | N/A |
#8 | $3.7M | 24 | -8% | N/A | N/A |
#9 | $2M | 13 | 18% | N/A | N/A |
#10 | $9.3M | 60 | 2% | N/A | N/A |
What Is SFA Therapeutics?
SFA Therapeutics is a clinical stage start-up biotech company developing compounds discovered in human microbiome. This patented and proprietary platform is based on immuno-modulation of inflammatory factors derived from human gut microbiome. The technology is licensed from and supported by research at Temple University in Philadelphia. These products are a unique native immunotherapy platform with activity currently being investigated in cancer, liver, and auto-immune disease.
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 12 | 0% | N/A |
#2 | $1M | 12 | N/A | N/A |
#3 | $1.8M | 12 | 50% | N/A |
#4 | $1M | 12 | 33% | N/A |
#5 | $4M | 23 | 35% | N/A |